US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.80

+0.04500.03%

Volume:637.13K

Turnover:85.86M

Market Cap:10.16B

PE:-31.06

High:134.81

Open:134.79

Low:134.71

Close:134.75

52wk High:134.88

52wk Low:35.39

Shares:75.34M

Float Shares:58.14M

Volume Ratio:0.53

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3400

EPS(LYR):-4.2155

ROE:-32.46%

ROA:-20.30%

PB:8.50

PE(LYR):-31.98

Loading ...

Overview Company News Filings

Apogee Therapeutics price target lowered to $81 from $83 at Truist

Apogee Therapeutics Is Maintained at Outperform by Wedbush

BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio

Wedbush Raises Price Target on Apogee Therapeutics to $135 From $120, Keeps Outperform Rating

MT Newswires Live

BUZZ-Apogee Therapeutics reports results from mid-stage skin disease therapy; shares fall

Apogee Secures $1.3 Billion Financing From Blackstone as Lead Drug Posts Strong Phase-2 Results

Apogee Therapeutics Potential Atopic Dermatitis Treatment Meets Primary, Secondary Endpoints in Mid-Stage Trial

MT Newswires Live

Apogee Therapeutics Shares Fall 19% Premarket After Mid-Stage Trial Results of Its Atopic Dermatitis Antibody, $1.3 Bln Blackstone Financing Collaboration

THOMSON REUTERS

Apogee Therapeutics Inc - Blackstone Life Sciences to Pay $100 Mln Upfront for Revenue Share on Zumilokibart Sales - SEC Filing

THOMSON REUTERS

Apogee Therapeutics signs financing deal with Blackstone Life Sciences for up to $1.3 billion

Apogee Therapeutics Inc - up to $400 Mln Additional Funding Available Upon FDA Approval of Zumilokibart

THOMSON REUTERS

Apogee Therapeutics Inc - First $400 Mln Preapproval Funding in 3 Tranches Based on Development Milestones

THOMSON REUTERS

Apogee Therapeutics Inc - Removes Cash Runway End Date Guidance After Blackstone Agreement

THOMSON REUTERS

Apogee Therapeutics Inc - Deal Includes up to $800 Mln Synthetic Royalty and up to $500 Mln Senior Debt

THOMSON REUTERS

Apogee Therapeutics Inc - to Advance Mid-Dose Zumilokibart to Phase 3 Trials in Ad in 2H 2026

THOMSON REUTERS

Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results From Phase 2 Apex Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis

THOMSON REUTERS

Apogee Therapeutics Inc - Zumilokibart Shows Favorable Safety Profile Consistent With Class

THOMSON REUTERS

Apogee Therapeutics Inc - Phase 2 Apex Clinical Trial Met Its Primary and Secondary Endpoints

THOMSON REUTERS

Apogee Therapeutics Inc - Announces Strategic Financing Collaboration With Blackstone Life Sciences

THOMSON REUTERS

MEDIA-Blackstone injecting up to $1.3 billion in Apogee for skin drug - Bloomberg News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/APGE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":134.795,"timestamp":1787599873128,"preClose":134.75,"halted":0,"volume":637127,"delay":0,"changeRate":0.0003339517625230983,"floatShares":58137500,"shares":75339900,"eps":-4.34,"marketStatus":"Trading","change":0.045,"latestTime":"08-24 15:31:19 EDT","open":134.79,"high":134.81,"low":134.71,"amount":85858489.08140999,"amplitude":0.000742,"askPrice":134.8,"askSize":898,"bidPrice":134.79,"bidSize":1263,"shortable":3,"etf":0,"ttmEps":-4.34,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":134.75,"preHourTrading":{"tag":"盘前","latestPrice":134.75,"preClose":134.75,"latestTime":"09:29 EDT","volume":90,"amount":12125.6793,"timestamp":1787578199992,"change":0,"changeRate":0,"amplitude":0.0043},"postHourTrading":{"tag":"盘后","latestPrice":134.75,"preClose":134.75,"latestTime":"19:30 EDT","volume":37638,"amount":5071747.5,"timestamp":1787355006972,"change":0,"changeRate":0,"amplitude":0.001336},"volumeRatio":0.530416,"impliedVol":0.1646,"impliedVolPercentile":0.0996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":58137500,"roa":"-20.30%","roe":"-32.46%","lyrEps":-4.215513,"volumeRatio":0.530416,"shares":75339900,"dividePrice":0,"high":134.81,"amplitude":0.000742,"preClose":134.75,"low":134.71,"week52Low":35.39,"pbRate":"8.50","week52High":134.88,"institutionHeld":0,"latestPrice":134.795,"committee":0.168903,"eps":-4.34,"divideRate":0,"volume":637127,"delay":0,"ttmEps":-4.34,"open":134.79,"prevYearClose":75.48,"prevWeekClose":134.75,"prevMonthClose":134.09,"prevQuarterClose":132.73,"fiveDayClose":134.59,"twentyDayClose":134.28,"sixtyDayClose":77.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"APGE","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-1.14},{"market":"US","date":"2026-05-11","symbol":"APGE","fiscalQuarterEnding":"2026/03","expectedEps":-1.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2026-03-02","symbol":"APGE","fiscalQuarterEnding":"2025/12","expectedEps":-1.05,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-11-10","symbol":"APGE","fiscalQuarterEnding":"2025/09","expectedEps":-1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2025-08-11","symbol":"APGE","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0667,"hold":0.9333,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9333,"analysts":15,"updateTime":1786593600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2026-08-21","current":-31.048387,"percent":0.092715,"low":-42.099968,"twenty":-25.999346,"median":-19.423136,"eighty":-12.51704,"high":-8.51736,"avg":-20.424875,"sd":8.051869,"marketCap":10162217065},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526},{"date":"2025-07-25","current":-11.833421,"twenty":-26.172746,"median":-18.534,"eighty":-12.51704,"marketCap":2430478247},{"date":"2025-08-01","current":-10.872879,"twenty":-26.165436,"median":-18.435064,"eighty":-12.454858,"marketCap":2233191588},{"date":"2025-08-08","current":-10.230624,"twenty":-26.144692,"median":-18.356106,"eighty":-12.348931,"marketCap":2101278024},{"date":"2025-08-15","current":-9.370325,"twenty":-26.131061,"median":-18.310909,"eighty":-12.239332,"marketCap":2227054492},{"date":"2025-08-22","current":-8.957767,"twenty":-26.099427,"median":-18.29345,"eighty":-12.125473,"marketCap":2129001470},{"date":"2025-08-29","current":-9.024303,"twenty":-26.061716,"median":-18.235984,"eighty":-12.057962,"marketCap":2144815236},{"date":"2025-09-05","current":-9.149983,"twenty":-26.050112,"median":-18.048125,"eighty":-11.971712,"marketCap":2174685683},{"date":"2025-09-12","current":-9.184484,"twenty":-25.999346,"median":-17.978348,"eighty":-11.914309,"marketCap":2182885414},{"date":"2025-09-19","current":-9.470344,"twenty":-25.989488,"median":-17.837569,"eighty":-11.833421,"marketCap":2250826038},{"date":"2025-09-26","current":-9.246091,"twenty":-25.963085,"median":-17.587319,"eighty":-11.751667,"marketCap":2197527790},{"date":"2025-10-03","current":-9.761132,"twenty":-25.927394,"median":-17.537558,"eighty":-11.64586,"marketCap":2319938053},{"date":"2025-10-10","current":-13.112594,"twenty":-25.927394,"median":-17.474803,"eighty":-11.60039,"marketCap":3116483307},{"date":"2025-10-17","current":-14.719201,"twenty":-25.919571,"median":-17.381927,"eighty":-11.6264,"marketCap":3498327236},{"date":"2025-10-24","current":-14.83497,"twenty":-25.825784,"median":-17.31961,"eighty":-11.641401,"marketCap":3525842169},{"date":"2025-10-31","current":-15.446892,"twenty":-25.767274,"median":-17.151542,"eighty":-11.64586,"marketCap":3671278245},{"date":"2025-11-07","current":-15.158848,"twenty":-25.763689,"median":-17.013102,"eighty":-11.649617,"marketCap":3602818471},{"date":"2025-11-14","current":-16.75274,"twenty":-25.752769,"median":-16.901067,"eighty":-11.702697,"marketCap":4249734472},{"date":"2025-11-21","current":-16.859157,"twenty":-25.643182,"median":-16.952708,"eighty":-11.751008,"marketCap":4276729768},{"date":"2025-11-28","current":-19.147128,"twenty":-25.58,"median":-17.00282,"eighty":-11.751535,"marketCap":4857128632},{"date":"2025-12-05","current":-20.086261,"twenty":-25.516057,"median":-17.081704,"eighty":-11.751783,"marketCap":5095362120},{"date":"2025-12-12","current":-20.360285,"twenty":-25.476749,"median":-17.24758,"eighty":-11.795704,"marketCap":5164875007},{"date":"2025-12-19","current":-20.578441,"twenty":-25.464129,"median":-17.327965,"eighty":-11.813694,"marketCap":5220215364},{"date":"2025-12-26","current":-20.775313,"twenty":-25.437705,"median":-17.381927,"eighty":-11.826232,"marketCap":5270156661},{"date":"2026-01-02","current":-20.08094,"twenty":-25.407235,"median":-17.443781,"eighty":-11.835695,"marketCap":5094012355},{"date":"2026-01-09","current":-20.613026,"twenty":-25.376631,"median":-17.517481,"eighty":-11.841525,"marketCap":5228988835},{"date":"2026-01-16","current":-21.482988,"twenty":-25.344147,"median":-17.566657,"eighty":-11.865469,"marketCap":5449675380},{"date":"2026-01-23","current":-21.246209,"twenty":-25.316184,"median":-17.607671,"eighty":-11.899615,"marketCap":5389610846},{"date":"2026-01-30","current":-18.617702,"twenty":-25.310382,"median":-17.773551,"eighty":-11.916319,"marketCap":4722827035},{"date":"2026-02-06","current":-16.529263,"twenty":-25.299938,"median":-17.629714,"eighty":-11.92777,"marketCap":4193044351},{"date":"2026-02-13","current":-18.439453,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"marketCap":4677609914},{"date":"2026-02-20","current":-18.338357,"twenty":-25.252364,"median":-17.631406,"eighty":-11.950995,"marketCap":4651964383},{"date":"2026-02-27","current":-18.380924,"twenty":-25.237859,"median":-17.924865,"eighty":-11.971712,"marketCap":4662762501},{"date":"2026-03-06","current":-19.084656,"twenty":-25.237859,"median":-18.011929,"eighty":-12.048249,"marketCap":4882675550},{"date":"2026-03-13","current":-19.781628,"twenty":-25.201598,"median":-18.048125,"eighty":-12.051438,"marketCap":5060990972},{"date":"2026-03-20","current":-18.433431,"twenty":-25.17554,"median":-18.05103,"eighty":-12.057816,"marketCap":4716064230},{"date":"2026-03-27","current":-22.635495,"twenty":-25.092814,"median":-18.211825,"eighty":-12.058545,"marketCap":5791132948},{"date":"2026-04-02","current":-24.315405,"twenty":-25.034796,"median":-18.255434,"eighty":-12.060324,"marketCap":6220926288},{"date":"2026-04-10","current":-24.973515,"twenty":-25.014384,"median":-18.297329,"eighty":-12.063509,"marketCap":6389298937},{"date":"2026-04-17","current":-26.136752,"twenty":-25.109359,"median":-18.322222,"eighty":-12.100103,"marketCap":6686904979},{"date":"2026-04-24","current":-25.484415,"twenty":-25.24076,"median":-18.338357,"eighty":-12.174653,"marketCap":6520009283},{"date":"2026-05-01","current":-23.925736,"twenty":-25.237859,"median":-18.357757,"eighty":-12.211865,"marketCap":6121231957},{"date":"2026-05-08","current":-23.887288,"twenty":-25.20885,"median":-18.380924,"eighty":-12.222332,"marketCap":6111395326},{"date":"2026-05-15","current":-22.900754,"twenty":-25.180752,"median":-18.433431,"eighty":-12.226576,"marketCap":6288890455},{"date":"2026-05-22","current":-22.496831,"twenty":-25.109359,"median":-18.46514,"eighty":-12.275404,"marketCap":6177967349},{"date":"2026-05-29","current":-21.238668,"twenty":-25.059336,"median":-18.527248,"eighty":-12.293604,"marketCap":5832456861},{"date":"2026-06-05","current":-24.808467,"twenty":-25.026981,"median":-18.566539,"eighty":-12.31583,"marketCap":6812777290},{"date":"2026-06-12","current":-24.426379,"twenty":-25.015861,"median":-18.628344,"eighty":-12.336427,"marketCap":6707850027},{"date":"2026-06-18","current":-24.134354,"twenty":-25.012907,"median":-18.658155,"eighty":-12.355752,"marketCap":6627655619},{"date":"2026-06-26","current":-36.211083,"twenty":-25.070495,"median":-18.735668,"eighty":-12.378968,"marketCap":9944106610},{"date":"2026-07-02","current":-36.235646,"twenty":-25.230607,"median":-18.783693,"eighty":-12.388203,"marketCap":9950851934},{"date":"2026-07-10","current":-36.453982,"twenty":-25.299938,"median":-18.859802,"eighty":-12.416911,"marketCap":10010810370},{"date":"2026-07-17","current":-36.593172,"twenty":-25.381567,"median":-18.941441,"eighty":-12.454858,"marketCap":10049033873},{"date":"2026-07-24","current":-36.706227,"twenty":-25.481518,"median":-19.08331,"eighty":-12.473884,"marketCap":10080080493},{"date":"2026-07-31","current":-36.717163,"twenty":-25.564204,"median":-19.092697,"eighty":-12.473884,"marketCap":10083083645},{"date":"2026-08-07","current":-36.769108,"twenty":-25.767274,"median":-19.147128,"eighty":-12.501095,"marketCap":10097348618},{"date":"2026-08-14","current":-34.444709,"twenty":-25.927394,"median":-19.256206,"eighty":-12.51704,"marketCap":10139592463},{"date":"2026-08-21","current":-34.521566,"twenty":-25.999346,"median":-19.423136,"eighty":-12.51704,"marketCap":10162217065}],"updateTime":1787576899790},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638687824","title":"Apogee Therapeutics price target lowered to $81 from $83 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2638687824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638687824?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:53","pubTimestamp":1779900809,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill lowered the firm’s price target on Apogee Therapeutics (APGE) to $81 from $83 and keeps a Hold rating on the shares. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-price-target-lowered-to-81-from-83-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-price-target-lowered-to-81-from-83-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638445685","title":"Apogee Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2638445685","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638445685?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:47","pubTimestamp":1779889620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 09:47 ET (13:47 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638683535","title":"BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2638683535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638683535?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:04","pubTimestamp":1779887095,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 BioWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL6N4240LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","LU0642271901.SGD","LU2264538146.SGD","ANF","LU0742534661.SGD","LU2129689605.HKD","LU1718418525.SGD","LU2102340556.USD","BK4532","BK4534","CPRI","SGXZ23171101.USD","LU2360032135.SGD","SG9999002521.SGD","LU2125154778.USD","LU0323240290.USD","LU2347655156.SGD","LU0211327993.USD","LU1674673428.USD","BK4202","LU0345781412.USD","LU1582987324.SGD","LU2065169927.USD","LU1084165304.USD","BK4579","IE00B1XK9C88.USD","FANG","LU1914381329.SGD","LU2357305700.SGD","SG9999002232.USD","LU2286300806.USD","LU0320765489.SGD","LU1074936037.SGD","LU1585245621.USD","LU2065170008.USD","BK4082","LU0471298777.SGD","LU0417517546.SGD","LU1883866441.USD","HIMY","IE00B19Z3581.USD","BK4516","LU2211815571.USD","LU0109392836.USD","HIMZ","LU0320765646.SGD","LU1861219969.SGD","LU0070217475.USD","DKS","LU2357627491.SGD","LU1430594728.SGD","LU2954938101.SGD","LU0300736492.USD","DE","LU0648000940.SGD","IE00BGHQF524.EUR","LU0266512473.USD","LU1496350171.SGD","LU2168564149.EUR","LU0098860793.USD","LU1366333091.USD","LU0082616367.USD","QTTB","LU0792757196.USD","IE00BKVL7J92.USD","LU0980610538.SGD","LU0175139822.USD","LU1430597077.USD","LU2462611646.USD","SG9999014567.USD","IE00BKDWB100.SGD","SMTC","SG9999014575.USD","LU0795875169.SGD","XOM","LU0511384066.AUD","APGE","LU0654597011.USD","SG9999002224.SGD","BK4139","SG9999015341.SGD","LU0203347892.USD","IE00BZ199S13.USD","LU2471134796.USD","HMYY","PODD","LU1064131342.USD","LU1989763427.SGD","LU2471134879.HKD","LU0289960550.SGD","LU0957791311.USD","LU0130517989.USD","LU0612318971.USD","LU0868494617.USD","GB00BDT5M118.USD","BK4533","LU0203345920.USD","LU0640476718.USD","LU0719512351.SGD","LU2054465674.USD","LU1066051498.USD","MUD","BK4566","LU1894683264.USD","LU1267930813.SGD","SG9999014542.SGD","LU2462591277.SGD","CVX","LU0149725797.USD","LU0154236417.USD","LU2168564495.EUR","LU1732799900.SGD","LU0868494708.USD","LU0787776722.HKD","LU2498475776.HKD","LU2125909759.SGD","LU0289739343.SGD","LU0310799852.SGD","SG9999001440.SGD","SG9999014559.SGD","HIYY","IE00B7SZLL34.SGD","PONY","IE0004445239.USD","LU0068578508.USD","LU2168564222.USD","BK4605","LU2394011477.USD","LU2133065610.SGD","LU1852331112.SGD","SG9999011175.SGD","LU1803068979.SGD","FLY","LU0143551892.USD","MGM","LU1201861165.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","LU0081259029.USD","LU0205193047.USD","IE00BWXC8680.SGD","LU1119994496.HKD","LU2471134523.USD","BK4553","LU2999663052.SGD","02026","LU1917777945.USD","LU1923622291.USD","LU1069347547.HKD","BK4543","BK4575","SG9999003800.SGD","LU2750360641.GBP","LU1674673691.USD","LU1506573853.SGD","LU0278409577.USD","IE000M9KFDE8.USD","LU0130102774.USD","LU1861214812.USD","LU2931357623.SGD","COP","FPS","LU2487616109.SGD","BK4150","BK4550","LU0251131958.USD","LU1732800096.USD","BK4182","LU0985489474.SGD","SG9999004303.SGD","LU1929549753.HKD","LU0648001328.SGD","LU1988902786.USD","BK4554","BK4094","HIMS","BBWI","LU1150488218.USD","LU0345780950.USD","LU1496350502.SGD","LU0889566641.SGD","LU1162221912.USD","LU2023250504.SGD","LU0942090050.USD","LU2250418816.HKD","LU1582986359.USD","IE00BFXG1179.USD","LU0251142724.SGD","LU2750360997.AUD","LU1720051017.SGD","LU2211817866.USD","LU0070302665.USD","BK4527","LU1035773651.USD","LU1489326972.SGD","LU2430703251.USD","LU1989763690.USD","BK4200","LU2089985449.USD","LU1116320737.USD","LU2430703095.HKD","LU0912757837.SGD","LU2125154935.USD","LU2106854487.HKD","LU0795875086.SGD","LU0238689110.USD","LU0053671581.USD","LU1582987597.SGD","LU0289961442.SGD","IE0002270589.USD","LU2381873111.SGD","BK4152","IE00BD6J9T35.USD","LU1261432733.SGD","LU1720051108.HKD","BK4023","LU0889565833.HKD","LU2491049909.HKD","LU0683600562.USD","LU2023250843.SGD","LU2592432038.USD","LU1839511570.USD","LU0265550359.USD","LU1548497426.USD","LU2065171311.SGD","LU0345770308.USD","LU0056508442.USD","BK4581","BK4585","LU0300736062.USD","BK4187","XOMO","LU0612318385.USD","LU0456854461.SGD","LU0345770993.USD","LU0130103400.USD","LU0788109394.HKD","LU1280957306.USD","LU0205194284.USD","SG9999015358.SGD","LU0106261612.USD","IE00B2Q91V27.USD","LU1894683348.USD","LU1316542783.SGD","LU1571399168.USD","LU0256331488.USD","LU2129689514.USD","LU0477156953.USD","LU0630314457.HKD","BK4560","LU0368265418.SGD","LU0314106906.USD","LU0433182093.SGD","LU2324357040.USD","LU0385154629.USD","LU2491050071.SGD","LU1201861249.SGD","LU0728928796.USD","LU0053666078.USD","LU2471134952.CNY","XOMX","LU0061474960.USD","LU0127658192.USD","LU0122376428.USD","BK4559","BK4196","PONX","LU0390134368.USD","LU0878866978.SGD","IE0034235303.USD","IE00B3CCJ963.GBP","XOMZ","LU1323610961.USD","LU2543165471.USD","LU1815333072.USD","LU1116320901.HKD","LU0312595415.SGD","LU1582986433.USD","BK4213","LU2129689431.USD","FLYT","IE00B1BXHZ80.USD","BK4570","LU2065171402.SGD","LU0211328371.USD","LU0256863811.USD","LU2505996509.AUD","IE00B5949003.HKD","BK4512","LU2458330169.SGD","LU1974910355.USD","LU0048573561.USD","IE0009356076.USD","MUU","LU2491050154.USD","LU0274383776.USD","LU2360106780.USD","LU0210528500.USD","LU2125909916.SGD","LU0266512127.USD","LU0208291251.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU2168564065.EUR","LU0234572021.USD","LU0012050646.USD","LU0466842654.USD","LU0859254822.USD","LU1150488135.SGD","LU2505996681.GBP","LU1267930490.SGD","ZS","BK4588","MULL","BK4097","LU2458330243.SGD","BK4592","LU2048586759.USD","LU0157215616.USD","BK4141","BK4551","BK4561","LU2602419157.SGD","LU2168563687.JPY","LU0265550946.USD","LU1778281490.HKD","LU0170899867.USD","LU2430703178.SGD","MU","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638668507","title":"Wedbush Raises Price Target on Apogee Therapeutics to $135 From $120, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2638668507","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638668507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:57","pubTimestamp":1779883041,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $119.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507357","title":"BUZZ-Apogee Therapeutics reports results from mid-stage skin disease therapy; shares fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507357","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507357?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:49","pubTimestamp":1779882573,"startTime":"0","endTime":"0","summary":"BUZZ-Apogee Therapeutics reports results from mid-stage skin disease therapy; shares fall ** Shares of Apogee Therapeutics APGE.O slide 11.4% to $73.34 premarket ** The drug developer says its experimental skin disease therapy met the main goal in results from part B of its mid-stage study** Adds that 65.9% of patients treated with mid-dose zumilokibart showed significant improvement in their eczema ** Plans to move forward with the mid-dose for late-stage studies ** Brokerage Stifel says results \"near identical\" as prior part A data for the mid-dose** \"While pushing exposure vs. the prior study did not achieve differentiated outcomes, we ultimately don't think it matters and view the highly competitive efficacy/dosing profile as attractive at this valuation\" - Stifel** APGE was testing the treatment in patients with moderate-to-severe atopic dermatitis a chronic, inflammatory skin condition** The firm also announces an up to $1.3 billion financing collaboration with Blackstone Life Sc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL4N4240YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638023035","title":"Apogee Secures $1.3 Billion Financing From Blackstone as Lead Drug Posts Strong Phase-2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2638023035","media":"Dow Jones","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638023035?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:24","pubTimestamp":1779881040,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics secured $1.3 billion in financing from Blackstone Life Sciences and reported strong phase-2 results for its dermatitis treatment.The clinical-stage biotechnology company said Wednesday that the new funds will go toward advancing its lead drug, zumilokibart, through phase-3 trials and into commercialization.The drug aims to treat moderate-to-severe atopic dermatitis, which is the more intense, chronic form of eczema, where the skin inflation persists and can significantly affect daily life.The financing is nondilutive, and is one of Blackstone Life Science's largest royalty financing for a pre-phase 3 program to date. The up-to $1.3 billion is made up of $800 million of synthetic royalty and up to $500 million of senior debt.Blackstone will receive returns from tiered royalties for a term of 15 years on worldwide annual sales of zumilokibart.The news follows Apogee's positive data from part B of the phase 2 Apex clinical study of the treatment, which found that zumil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","IE0004445239.USD","LU0053671581.USD","BK4135","IE00B3QW5Z07.USD","APGE","BK4585","IE00BGHQF748.EUR","BK4139","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4588","BX","IE00B64PRP62.GBP","IE00BN8TJ469.HKD","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638504248","title":"Apogee Therapeutics Potential Atopic Dermatitis Treatment Meets Primary, Secondary Endpoints in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638504248","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638504248?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:11","pubTimestamp":1779880262,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics'  zumilokibart as a potential treatment in moderate-to-severe atopic dermatitis has met all primary and secondary endpoints \"with high statistical significance\" in a mid-stage trial, the clinical-stage company said Wednesday.Mid-dose zumilokibart was well tolerated with a safety profile consistent with other treatments during the 16-week trial, the company said.The company plans to begin late-stage trials in H2, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0053671581.USD","BK4139","SSI","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638501119","title":"Apogee Therapeutics Shares Fall 19% Premarket After Mid-Stage Trial Results of Its Atopic Dermatitis Antibody, $1.3 Bln Blackstone Financing Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638501119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638501119?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:45","pubTimestamp":1779878736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL4N4240UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638501667","title":"Apogee Therapeutics Inc - Blackstone Life Sciences  to Pay $100 Mln Upfront for Revenue Share on Zumilokibart Sales - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638501667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638501667?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:41","pubTimestamp":1779878515,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4240P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638886501","title":"Apogee Therapeutics signs financing deal with Blackstone Life Sciences for up to $1.3 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2638886501","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638886501?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:31","pubTimestamp":1779877901,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics entered a strategic financing collaboration with Blackstone Life Sciences for up to USD 1.3 billion in non-dilutive capital.Package includes up to USD 800 million of synthetic royalty funding tied to low-to-mid single-digit tiered royalties on zumilokibart sales for 15 years.Royalties step down as sales rise, with no royalties on global annual sales above USD 8 billion.Also provides access to up to USD 500 million of senior corporate debt, subject to mutual consent.Apogee withdrew cash runway end-date guidance, citing the new financing alongside USD 1.3 billion in existing cash.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL4R5Xfw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0053671581.USD","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","BK4139","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","APGE","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638750904","title":"Apogee Therapeutics Inc - up to $400 Mln Additional Funding Available Upon FDA Approval of Zumilokibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2638750904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638750904?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:31","pubTimestamp":1779877860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA3TPNKL:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","IE00BN8TJ469.HKD","BK4588","IE0004445239.USD","BK4139","IE00BGHQF748.EUR","LU0053671581.USD","BX","IE00B64PRP62.GBP","IE00BLSP4239.USD","IE00B3QW5Z07.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4135","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509072","title":"Apogee Therapeutics Inc - First $400 Mln Preapproval Funding in 3 Tranches Based on Development Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509072?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:31","pubTimestamp":1779877860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA3TPNKL:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IE00BN8TJ469.HKD","LU0053671581.USD","BK4135","BX","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BLSP4452.SGD","APGE","IE00BLSP4239.USD","BK4139","IE0004445239.USD","IE00BBT3K403.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509040","title":"Apogee Therapeutics Inc - Removes Cash Runway End Date Guidance After Blackstone Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509040?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:31","pubTimestamp":1779877860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA3TPNKL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638042509","title":"Apogee Therapeutics Inc - Deal Includes up to $800 Mln Synthetic Royalty and up to $500 Mln Senior Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2638042509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638042509?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:31","pubTimestamp":1779877860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA3TPNKL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","BX","IE00BBT3K403.USD","BK4139","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","APGE","IE0004445239.USD","BK4135","BK4585","IE00B3QW5Z07.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509703","title":"Apogee Therapeutics Inc - to Advance Mid-Dose Zumilokibart to Phase 3 Trials in Ad in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509703?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:30","pubTimestamp":1779877800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6VHYMV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509299","title":"Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results From Phase 2 Apex Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509299?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:30","pubTimestamp":1779877800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6VHYMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509089","title":"Apogee Therapeutics Inc - Zumilokibart Shows Favorable Safety Profile Consistent With Class","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509089?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:30","pubTimestamp":1779877800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6VHYMV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509049","title":"Apogee Therapeutics Inc -  Phase 2 Apex Clinical Trial Met Its Primary and Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509049?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:30","pubTimestamp":1779877800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6VHYMV:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638082509","title":"Apogee Therapeutics Inc - Announces Strategic Financing Collaboration With Blackstone Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2638082509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638082509?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:30","pubTimestamp":1779877800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6VHYMV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638850914","title":"MEDIA-Blackstone injecting up to $1.3 billion in Apogee for skin drug - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2638850914","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638850914?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:22","pubTimestamp":1779877332,"startTime":"0","endTime":"0","summary":"MEDIA-Blackstone injecting up to $1.3 billion in Apogee for skin drug - Bloomberg News-- Source link: https://tinyurl.com/4kb5d3pm-- Note: Reuters has not verified this story and does not vouch for its accuracy ((globalnewsmonitoring@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL4N4240T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4135","IE0004445239.USD","IE00BGHQF748.EUR","BK4139","BK4588","APGE","IE00B64PRP62.GBP","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","LU0053671581.USD","IE00BBT3K403.USD","BX","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":197,"code":"91000000","status":"200"}]}}